ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Finasteride (Oral Route) Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-18E16798
Home | Market Reports | Health| Pharmacy
Global Finasteride Oral Route Market Research Report 2024
BUY CHAPTERS

Global Finasteride (Oral Route) Market Research Report 2025

Code: QYRE-Auto-18E16798
Report
September 2025
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Sandoz Inc
Actavis
Cipla Ltd
RelonChem
Dr. Reddy
Accord Pharmaceuticals
Hangzhou Kangenbei Pharmaceutical Co., Ltd
Hunan Zhengqing Pharmaceutical Group Co., Ltd
Tianfang Pharmaceutical Co., Ltd
Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd
Zhejiang Xianju Pharmaceutical Co., Ltd.
Shanghai Hyundai Pharmaceutical Co., Ltd
Hunan Baicao Pharmaceutical Co., Ltd.
Guangdong Yishu Pharmaceutical Co., Ltd
CR SECCO Pharmaceutical Co., Ltd
Shanghai Xinya Pharmaceutical Minhang Co., Ltd.
Renhetang Pharmaceutical Company Limited
Runenberg Pharmaceuticals Ltd
Nanjing Shenghe Pharmaceutical Co., Ltd.
Nanjing Sea Whale Pharmaceutical Co., Ltd.

Finasteride (Oral Route) Market

The global market for Finasteride (Oral Route) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Finasteride, when taken orally, is a medication used to treat symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate. It is also prescribed to treat male pattern hair loss (androgenetic alopecia) in men. Finasteride works by inhibiting the action of the enzyme 5-alpha reductase, which converts the male hormone testosterone to dihydrotestosterone (DHT). By reducing DHT levels in the body, finasteride helps to shrink the prostate and promote hair regrowth in men with male pattern baldness. It is important to note that finasteride should only be taken as prescribed by a healthcare provider, as it can have side effects and may not be suitable for everyone.
North American market for Finasteride (Oral Route) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Finasteride (Oral Route) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Finasteride (Oral Route) include Merck, Sandoz, Actavis, Cipla, RelonChem, Dr. Reddy, Accord Pharmaceuticals, Hangzhou Kangenbei Pharmaceutical Co., Ltd, Hunan Zhengqing Pharmaceutical Group Co., Ltd, Tianfang Pharmaceutical Co., Ltd, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Finasteride (Oral Route), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Finasteride (Oral Route).
The Finasteride (Oral Route) market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Finasteride (Oral Route) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Finasteride (Oral Route) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Finasteride (Oral Route) Market Report

Report Metric Details
Report Name Finasteride (Oral Route) Market
Segment by Type
  • 1mg
  • 5mg
Segment by Application
  • Urology
  • Dermatology
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Sandoz, Actavis, Cipla, RelonChem, Dr. Reddy, Accord Pharmaceuticals, Hangzhou Kangenbei Pharmaceutical Co., Ltd, Hunan Zhengqing Pharmaceutical Group Co., Ltd, Tianfang Pharmaceutical Co., Ltd, Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd, Zhejiang Xianju Pharmaceutical Co., Ltd, Shanghai Hyundai Pharmaceutical Co., Ltd, Hunan Baicao Pharmaceutical Co., Ltd, Guangdong Yishu Pharmaceutical Co., Ltd, CR SECCO Pharmaceutical Co., Ltd, Shanghai Xinya Pharmaceutical Minhang Co., Ltd, Renhetang Pharmaceutical Company Limited, Runenberg Pharmaceuticals Ltd, Nanjing Shenghe Pharmaceutical Co., Ltd, Nanjing Sea Whale Pharmaceutical Co., Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Finasteride (Oral Route) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Finasteride (Oral Route) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Finasteride (Oral Route) Market report?

Ans: The main players in the Finasteride (Oral Route) Market are Merck, Sandoz, Actavis, Cipla, RelonChem, Dr. Reddy, Accord Pharmaceuticals, Hangzhou Kangenbei Pharmaceutical Co., Ltd, Hunan Zhengqing Pharmaceutical Group Co., Ltd, Tianfang Pharmaceutical Co., Ltd, Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd, Zhejiang Xianju Pharmaceutical Co., Ltd, Shanghai Hyundai Pharmaceutical Co., Ltd, Hunan Baicao Pharmaceutical Co., Ltd, Guangdong Yishu Pharmaceutical Co., Ltd, CR SECCO Pharmaceutical Co., Ltd, Shanghai Xinya Pharmaceutical Minhang Co., Ltd, Renhetang Pharmaceutical Company Limited, Runenberg Pharmaceuticals Ltd, Nanjing Shenghe Pharmaceutical Co., Ltd, Nanjing Sea Whale Pharmaceutical Co., Ltd

What are the Application segmentation covered in the Finasteride (Oral Route) Market report?

Ans: The Applications covered in the Finasteride (Oral Route) Market report are Urology, Dermatology

What are the Type segmentation covered in the Finasteride (Oral Route) Market report?

Ans: The Types covered in the Finasteride (Oral Route) Market report are 1mg, 5mg

1 Finasteride (Oral Route) Market Overview
1.1 Product Definition
1.2 Finasteride (Oral Route) by Type
1.2.1 Global Finasteride (Oral Route) Market Value Comparison by Type (2024 VS 2031)
1.2.2 1mg
1.2.3 5mg
1.3 Finasteride (Oral Route) by Application
1.3.1 Global Finasteride (Oral Route) Market Value by Application (2024 VS 2031)
1.3.2 Urology
1.3.3 Dermatology
1.4 Global Finasteride (Oral Route) Market Size Estimates and Forecasts
1.4.1 Global Finasteride (Oral Route) Revenue 2020-2031
1.4.2 Global Finasteride (Oral Route) Sales 2020-2031
1.4.3 Global Finasteride (Oral Route) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Finasteride (Oral Route) Market Competition by Manufacturers
2.1 Global Finasteride (Oral Route) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Finasteride (Oral Route) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Finasteride (Oral Route) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Finasteride (Oral Route), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Finasteride (Oral Route), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Finasteride (Oral Route), Product Type & Application
2.7 Global Key Manufacturers of Finasteride (Oral Route), Date of Enter into This Industry
2.8 Global Finasteride (Oral Route) Market Competitive Situation and Trends
2.8.1 Global Finasteride (Oral Route) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Finasteride (Oral Route) Players Market Share by Revenue
2.8.3 Global Finasteride (Oral Route) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Finasteride (Oral Route) Market Scenario by Region
3.1 Global Finasteride (Oral Route) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Finasteride (Oral Route) Sales by Region: 2020-2031
3.2.1 Global Finasteride (Oral Route) Sales by Region: 2020-2025
3.2.2 Global Finasteride (Oral Route) Sales by Region: 2026-2031
3.3 Global Finasteride (Oral Route) Revenue by Region: 2020-2031
3.3.1 Global Finasteride (Oral Route) Revenue by Region: 2020-2025
3.3.2 Global Finasteride (Oral Route) Revenue by Region: 2026-2031
3.4 North America Finasteride (Oral Route) Market Facts & Figures by Country
3.4.1 North America Finasteride (Oral Route) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Finasteride (Oral Route) Sales by Country (2020-2031)
3.4.3 North America Finasteride (Oral Route) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Finasteride (Oral Route) Market Facts & Figures by Country
3.5.1 Europe Finasteride (Oral Route) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Finasteride (Oral Route) Sales by Country (2020-2031)
3.5.3 Europe Finasteride (Oral Route) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Finasteride (Oral Route) Market Facts & Figures by Region
3.6.1 Asia Pacific Finasteride (Oral Route) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Finasteride (Oral Route) Sales by Region (2020-2031)
3.6.3 Asia Pacific Finasteride (Oral Route) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Finasteride (Oral Route) Market Facts & Figures by Country
3.7.1 Latin America Finasteride (Oral Route) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Finasteride (Oral Route) Sales by Country (2020-2031)
3.7.3 Latin America Finasteride (Oral Route) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Finasteride (Oral Route) Market Facts & Figures by Country
3.8.1 Middle East and Africa Finasteride (Oral Route) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Finasteride (Oral Route) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Finasteride (Oral Route) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Finasteride (Oral Route) Sales by Type (2020-2031)
4.1.1 Global Finasteride (Oral Route) Sales by Type (2020-2025)
4.1.2 Global Finasteride (Oral Route) Sales by Type (2026-2031)
4.1.3 Global Finasteride (Oral Route) Sales Market Share by Type (2020-2031)
4.2 Global Finasteride (Oral Route) Revenue by Type (2020-2031)
4.2.1 Global Finasteride (Oral Route) Revenue by Type (2020-2025)
4.2.2 Global Finasteride (Oral Route) Revenue by Type (2026-2031)
4.2.3 Global Finasteride (Oral Route) Revenue Market Share by Type (2020-2031)
4.3 Global Finasteride (Oral Route) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Finasteride (Oral Route) Sales by Application (2020-2031)
5.1.1 Global Finasteride (Oral Route) Sales by Application (2020-2025)
5.1.2 Global Finasteride (Oral Route) Sales by Application (2026-2031)
5.1.3 Global Finasteride (Oral Route) Sales Market Share by Application (2020-2031)
5.2 Global Finasteride (Oral Route) Revenue by Application (2020-2031)
5.2.1 Global Finasteride (Oral Route) Revenue by Application (2020-2025)
5.2.2 Global Finasteride (Oral Route) Revenue by Application (2026-2031)
5.2.3 Global Finasteride (Oral Route) Revenue Market Share by Application (2020-2031)
5.3 Global Finasteride (Oral Route) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Finasteride (Oral Route) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Finasteride (Oral Route) Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Sandoz
6.2.1 Sandoz Company Information
6.2.2 Sandoz Description and Business Overview
6.2.3 Sandoz Finasteride (Oral Route) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sandoz Finasteride (Oral Route) Product Portfolio
6.2.5 Sandoz Recent Developments/Updates
6.3 Actavis
6.3.1 Actavis Company Information
6.3.2 Actavis Description and Business Overview
6.3.3 Actavis Finasteride (Oral Route) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Actavis Finasteride (Oral Route) Product Portfolio
6.3.5 Actavis Recent Developments/Updates
6.4 Cipla
6.4.1 Cipla Company Information
6.4.2 Cipla Description and Business Overview
6.4.3 Cipla Finasteride (Oral Route) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cipla Finasteride (Oral Route) Product Portfolio
6.4.5 Cipla Recent Developments/Updates
6.5 RelonChem
6.5.1 RelonChem Company Information
6.5.2 RelonChem Description and Business Overview
6.5.3 RelonChem Finasteride (Oral Route) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 RelonChem Finasteride (Oral Route) Product Portfolio
6.5.5 RelonChem Recent Developments/Updates
6.6 Dr. Reddy
6.6.1 Dr. Reddy Company Information
6.6.2 Dr. Reddy Description and Business Overview
6.6.3 Dr. Reddy Finasteride (Oral Route) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Dr. Reddy Finasteride (Oral Route) Product Portfolio
6.6.5 Dr. Reddy Recent Developments/Updates
6.7 Accord Pharmaceuticals
6.7.1 Accord Pharmaceuticals Company Information
6.7.2 Accord Pharmaceuticals Description and Business Overview
6.7.3 Accord Pharmaceuticals Finasteride (Oral Route) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Accord Pharmaceuticals Finasteride (Oral Route) Product Portfolio
6.7.5 Accord Pharmaceuticals Recent Developments/Updates
6.8 Hangzhou Kangenbei Pharmaceutical Co., Ltd
6.8.1 Hangzhou Kangenbei Pharmaceutical Co., Ltd Company Information
6.8.2 Hangzhou Kangenbei Pharmaceutical Co., Ltd Description and Business Overview
6.8.3 Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolio
6.8.5 Hangzhou Kangenbei Pharmaceutical Co., Ltd Recent Developments/Updates
6.9 Hunan Zhengqing Pharmaceutical Group Co., Ltd
6.9.1 Hunan Zhengqing Pharmaceutical Group Co., Ltd Company Information
6.9.2 Hunan Zhengqing Pharmaceutical Group Co., Ltd Description and Business Overview
6.9.3 Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Product Portfolio
6.9.5 Hunan Zhengqing Pharmaceutical Group Co., Ltd Recent Developments/Updates
6.10 Tianfang Pharmaceutical Co., Ltd
6.10.1 Tianfang Pharmaceutical Co., Ltd Company Information
6.10.2 Tianfang Pharmaceutical Co., Ltd Description and Business Overview
6.10.3 Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolio
6.10.5 Tianfang Pharmaceutical Co., Ltd Recent Developments/Updates
6.11 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd
6.11.1 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Company Information
6.11.2 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Description and Business Overview
6.11.3 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolio
6.11.5 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Recent Developments/Updates
6.12 Zhejiang Xianju Pharmaceutical Co., Ltd
6.12.1 Zhejiang Xianju Pharmaceutical Co., Ltd Company Information
6.12.2 Zhejiang Xianju Pharmaceutical Co., Ltd Description and Business Overview
6.12.3 Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolio
6.12.5 Zhejiang Xianju Pharmaceutical Co., Ltd Recent Developments/Updates
6.13 Shanghai Hyundai Pharmaceutical Co., Ltd
6.13.1 Shanghai Hyundai Pharmaceutical Co., Ltd Company Information
6.13.2 Shanghai Hyundai Pharmaceutical Co., Ltd Description and Business Overview
6.13.3 Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolio
6.13.5 Shanghai Hyundai Pharmaceutical Co., Ltd Recent Developments/Updates
6.14 Hunan Baicao Pharmaceutical Co., Ltd
6.14.1 Hunan Baicao Pharmaceutical Co., Ltd Company Information
6.14.2 Hunan Baicao Pharmaceutical Co., Ltd Description and Business Overview
6.14.3 Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolio
6.14.5 Hunan Baicao Pharmaceutical Co., Ltd Recent Developments/Updates
6.15 Guangdong Yishu Pharmaceutical Co., Ltd
6.15.1 Guangdong Yishu Pharmaceutical Co., Ltd Company Information
6.15.2 Guangdong Yishu Pharmaceutical Co., Ltd Description and Business Overview
6.15.3 Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolio
6.15.5 Guangdong Yishu Pharmaceutical Co., Ltd Recent Developments/Updates
6.16 CR SECCO Pharmaceutical Co., Ltd
6.16.1 CR SECCO Pharmaceutical Co., Ltd Company Information
6.16.2 CR SECCO Pharmaceutical Co., Ltd Description and Business Overview
6.16.3 CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue and Gross Margin (2020-2025)
6.16.4 CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolio
6.16.5 CR SECCO Pharmaceutical Co., Ltd Recent Developments/Updates
6.17 Shanghai Xinya Pharmaceutical Minhang Co., Ltd
6.17.1 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Company Information
6.17.2 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Description and Business Overview
6.17.3 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Product Portfolio
6.17.5 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Recent Developments/Updates
6.18 Renhetang Pharmaceutical Company Limited
6.18.1 Renhetang Pharmaceutical Company Limited Company Information
6.18.2 Renhetang Pharmaceutical Company Limited Description and Business Overview
6.18.3 Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Product Portfolio
6.18.5 Renhetang Pharmaceutical Company Limited Recent Developments/Updates
6.19 Runenberg Pharmaceuticals Ltd
6.19.1 Runenberg Pharmaceuticals Ltd Company Information
6.19.2 Runenberg Pharmaceuticals Ltd Description and Business Overview
6.19.3 Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Product Portfolio
6.19.5 Runenberg Pharmaceuticals Ltd Recent Developments/Updates
6.20 Nanjing Shenghe Pharmaceutical Co., Ltd
6.20.1 Nanjing Shenghe Pharmaceutical Co., Ltd Company Information
6.20.2 Nanjing Shenghe Pharmaceutical Co., Ltd Description and Business Overview
6.20.3 Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolio
6.20.5 Nanjing Shenghe Pharmaceutical Co., Ltd Recent Developments/Updates
6.21 Nanjing Sea Whale Pharmaceutical Co., Ltd
6.21.1 Nanjing Sea Whale Pharmaceutical Co., Ltd Company Information
6.21.2 Nanjing Sea Whale Pharmaceutical Co., Ltd Description and Business Overview
6.21.3 Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolio
6.21.5 Nanjing Sea Whale Pharmaceutical Co., Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Finasteride (Oral Route) Industry Chain Analysis
7.2 Finasteride (Oral Route) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Finasteride (Oral Route) Production Mode & Process Analysis
7.4 Finasteride (Oral Route) Sales and Marketing
7.4.1 Finasteride (Oral Route) Sales Channels
7.4.2 Finasteride (Oral Route) Distributors
7.5 Finasteride (Oral Route) Customer Analysis
8 Finasteride (Oral Route) Market Dynamics
8.1 Finasteride (Oral Route) Industry Trends
8.2 Finasteride (Oral Route) Market Drivers
8.3 Finasteride (Oral Route) Market Challenges
8.4 Finasteride (Oral Route) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck
Sandoz Inc
Actavis
Cipla Ltd
RelonChem
Dr. Reddy
Accord Pharmaceuticals
Hangzhou Kangenbei Pharmaceutical Co., Ltd
Hunan Zhengqing Pharmaceutical Group Co., Ltd
Tianfang Pharmaceutical Co., Ltd
Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd
Zhejiang Xianju Pharmaceutical Co., Ltd.
Shanghai Hyundai Pharmaceutical Co., Ltd
Hunan Baicao Pharmaceutical Co., Ltd.
Guangdong Yishu Pharmaceutical Co., Ltd
CR SECCO Pharmaceutical Co., Ltd
Shanghai Xinya Pharmaceutical Minhang Co., Ltd.
Renhetang Pharmaceutical Company Limited
Runenberg Pharmaceuticals Ltd
Nanjing Shenghe Pharmaceutical Co., Ltd.
Nanjing Sea Whale Pharmaceutical Co., Ltd.
List of Tables
 Table 1. Global Finasteride (Oral Route) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Finasteride (Oral Route) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Finasteride (Oral Route) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Finasteride (Oral Route) Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Finasteride (Oral Route) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Finasteride (Oral Route) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Finasteride (Oral Route) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Finasteride (Oral Route) Average Price (US$/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Finasteride (Oral Route), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Finasteride (Oral Route), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Finasteride (Oral Route), Product Type & Application
 Table 12. Global Key Manufacturers of Finasteride (Oral Route), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Finasteride (Oral Route) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Finasteride (Oral Route) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Finasteride (Oral Route) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Finasteride (Oral Route) Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Finasteride (Oral Route) Sales Market Share by Region (2020-2025)
 Table 19. Global Finasteride (Oral Route) Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Finasteride (Oral Route) Sales Market Share by Region (2026-2031)
 Table 21. Global Finasteride (Oral Route) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Finasteride (Oral Route) Revenue Market Share by Region (2020-2025)
 Table 23. Global Finasteride (Oral Route) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Finasteride (Oral Route) Revenue Market Share by Region (2026-2031)
 Table 25. North America Finasteride (Oral Route) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Finasteride (Oral Route) Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Finasteride (Oral Route) Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Finasteride (Oral Route) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Finasteride (Oral Route) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Finasteride (Oral Route) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Finasteride (Oral Route) Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Finasteride (Oral Route) Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Finasteride (Oral Route) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Finasteride (Oral Route) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Finasteride (Oral Route) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Finasteride (Oral Route) Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Finasteride (Oral Route) Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Finasteride (Oral Route) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Finasteride (Oral Route) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Finasteride (Oral Route) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Finasteride (Oral Route) Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Finasteride (Oral Route) Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Finasteride (Oral Route) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Finasteride (Oral Route) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Finasteride (Oral Route) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Finasteride (Oral Route) Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Finasteride (Oral Route) Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Finasteride (Oral Route) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Finasteride (Oral Route) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Finasteride (Oral Route) Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Finasteride (Oral Route) Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Finasteride (Oral Route) Sales Market Share by Type (2020-2025)
 Table 53. Global Finasteride (Oral Route) Sales Market Share by Type (2026-2031)
 Table 54. Global Finasteride (Oral Route) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Finasteride (Oral Route) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Finasteride (Oral Route) Revenue Market Share by Type (2020-2025)
 Table 57. Global Finasteride (Oral Route) Revenue Market Share by Type (2026-2031)
 Table 58. Global Finasteride (Oral Route) Price (US$/Pcs) by Type (2020-2025)
 Table 59. Global Finasteride (Oral Route) Price (US$/Pcs) by Type (2026-2031)
 Table 60. Global Finasteride (Oral Route) Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Finasteride (Oral Route) Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Finasteride (Oral Route) Sales Market Share by Application (2020-2025)
 Table 63. Global Finasteride (Oral Route) Sales Market Share by Application (2026-2031)
 Table 64. Global Finasteride (Oral Route) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Finasteride (Oral Route) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Finasteride (Oral Route) Revenue Market Share by Application (2020-2025)
 Table 67. Global Finasteride (Oral Route) Revenue Market Share by Application (2026-2031)
 Table 68. Global Finasteride (Oral Route) Price (US$/Pcs) by Application (2020-2025)
 Table 69. Global Finasteride (Oral Route) Price (US$/Pcs) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 73. Merck Finasteride (Oral Route) Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Sandoz Company Information
 Table 76. Sandoz Description and Business Overview
 Table 77. Sandoz Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 78. Sandoz Finasteride (Oral Route) Product
 Table 79. Sandoz Recent Developments/Updates
 Table 80. Actavis Company Information
 Table 81. Actavis Description and Business Overview
 Table 82. Actavis Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 83. Actavis Finasteride (Oral Route) Product
 Table 84. Actavis Recent Developments/Updates
 Table 85. Cipla Company Information
 Table 86. Cipla Description and Business Overview
 Table 87. Cipla Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 88. Cipla Finasteride (Oral Route) Product
 Table 89. Cipla Recent Developments/Updates
 Table 90. RelonChem Company Information
 Table 91. RelonChem Description and Business Overview
 Table 92. RelonChem Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 93. RelonChem Finasteride (Oral Route) Product
 Table 94. RelonChem Recent Developments/Updates
 Table 95. Dr. Reddy Company Information
 Table 96. Dr. Reddy Description and Business Overview
 Table 97. Dr. Reddy Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 98. Dr. Reddy Finasteride (Oral Route) Product
 Table 99. Dr. Reddy Recent Developments/Updates
 Table 100. Accord Pharmaceuticals Company Information
 Table 101. Accord Pharmaceuticals Description and Business Overview
 Table 102. Accord Pharmaceuticals Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 103. Accord Pharmaceuticals Finasteride (Oral Route) Product
 Table 104. Accord Pharmaceuticals Recent Developments/Updates
 Table 105. Hangzhou Kangenbei Pharmaceutical Co., Ltd Company Information
 Table 106. Hangzhou Kangenbei Pharmaceutical Co., Ltd Description and Business Overview
 Table 107. Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 108. Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Product
 Table 109. Hangzhou Kangenbei Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 110. Hunan Zhengqing Pharmaceutical Group Co., Ltd Company Information
 Table 111. Hunan Zhengqing Pharmaceutical Group Co., Ltd Description and Business Overview
 Table 112. Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 113. Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Product
 Table 114. Hunan Zhengqing Pharmaceutical Group Co., Ltd Recent Developments/Updates
 Table 115. Tianfang Pharmaceutical Co., Ltd Company Information
 Table 116. Tianfang Pharmaceutical Co., Ltd Description and Business Overview
 Table 117. Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 118. Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product
 Table 119. Tianfang Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 120. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Company Information
 Table 121. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Description and Business Overview
 Table 122. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 123. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product
 Table 124. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 125. Zhejiang Xianju Pharmaceutical Co., Ltd Company Information
 Table 126. Zhejiang Xianju Pharmaceutical Co., Ltd Description and Business Overview
 Table 127. Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 128. Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Product
 Table 129. Zhejiang Xianju Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 130. Shanghai Hyundai Pharmaceutical Co., Ltd Company Information
 Table 131. Shanghai Hyundai Pharmaceutical Co., Ltd Description and Business Overview
 Table 132. Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 133. Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Product
 Table 134. Shanghai Hyundai Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 135. Hunan Baicao Pharmaceutical Co., Ltd Company Information
 Table 136. Hunan Baicao Pharmaceutical Co., Ltd Description and Business Overview
 Table 137. Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 138. Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Product
 Table 139. Hunan Baicao Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 140. Guangdong Yishu Pharmaceutical Co., Ltd Company Information
 Table 141. Guangdong Yishu Pharmaceutical Co., Ltd Description and Business Overview
 Table 142. Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 143. Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Product
 Table 144. Guangdong Yishu Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 145. CR SECCO Pharmaceutical Co., Ltd Company Information
 Table 146. CR SECCO Pharmaceutical Co., Ltd Description and Business Overview
 Table 147. CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 148. CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Product
 Table 149. CR SECCO Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 150. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Company Information
 Table 151. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Description and Business Overview
 Table 152. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 153. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Product
 Table 154. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Recent Developments/Updates
 Table 155. Renhetang Pharmaceutical Company Limited Company Information
 Table 156. Renhetang Pharmaceutical Company Limited Description and Business Overview
 Table 157. Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 158. Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Product
 Table 159. Renhetang Pharmaceutical Company Limited Recent Developments/Updates
 Table 160. Runenberg Pharmaceuticals Ltd Company Information
 Table 161. Runenberg Pharmaceuticals Ltd Description and Business Overview
 Table 162. Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 163. Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Product
 Table 164. Runenberg Pharmaceuticals Ltd Recent Developments/Updates
 Table 165. Nanjing Shenghe Pharmaceutical Co., Ltd Company Information
 Table 166. Nanjing Shenghe Pharmaceutical Co., Ltd Description and Business Overview
 Table 167. Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 168. Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Product
 Table 169. Nanjing Shenghe Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 170. Nanjing Sea Whale Pharmaceutical Co., Ltd Company Information
 Table 171. Nanjing Sea Whale Pharmaceutical Co., Ltd Description and Business Overview
 Table 172. Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 173. Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Product
 Table 174. Nanjing Sea Whale Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 175. Key Raw Materials Lists
 Table 176. Raw Materials Key Suppliers Lists
 Table 177. Finasteride (Oral Route) Distributors List
 Table 178. Finasteride (Oral Route) Customers List
 Table 179. Finasteride (Oral Route) Market Trends
 Table 180. Finasteride (Oral Route) Market Drivers
 Table 181. Finasteride (Oral Route) Market Challenges
 Table 182. Finasteride (Oral Route) Market Restraints
 Table 183. Research Programs/Design for This Report
 Table 184. Key Data Information from Secondary Sources
 Table 185. Key Data Information from Primary Sources
 Table 186. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Finasteride (Oral Route)
 Figure 2. Global Finasteride (Oral Route) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Finasteride (Oral Route) Market Share by Type: 2024 & 2031
 Figure 4. 1mg Product Picture
 Figure 5. 5mg Product Picture
 Figure 6. Global Finasteride (Oral Route) Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Finasteride (Oral Route) Market Share by Application: 2024 & 2031
 Figure 8. Urology
 Figure 9. Dermatology
 Figure 10. Global Finasteride (Oral Route) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Finasteride (Oral Route) Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Finasteride (Oral Route) Sales (2020-2031) & (K Pcs)
 Figure 13. Global Finasteride (Oral Route) Average Price (US$/Pcs) & (2020-2031)
 Figure 14. Finasteride (Oral Route) Report Years Considered
 Figure 15. Finasteride (Oral Route) Sales Share by Manufacturers in 2024
 Figure 16. Global Finasteride (Oral Route) Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Finasteride (Oral Route) Players: Market Share by Revenue in Finasteride (Oral Route) in 2024
 Figure 18. Finasteride (Oral Route) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Finasteride (Oral Route) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Finasteride (Oral Route) Sales Market Share by Country (2020-2031)
 Figure 21. North America Finasteride (Oral Route) Revenue Market Share by Country (2020-2031)
 Figure 22. United States Finasteride (Oral Route) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Finasteride (Oral Route) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Finasteride (Oral Route) Sales Market Share by Country (2020-2031)
 Figure 25. Europe Finasteride (Oral Route) Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Finasteride (Oral Route) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Finasteride (Oral Route) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Finasteride (Oral Route) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Finasteride (Oral Route) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Finasteride (Oral Route) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Finasteride (Oral Route) Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Finasteride (Oral Route) Revenue Market Share by Region (2020-2031)
 Figure 33. China Finasteride (Oral Route) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Finasteride (Oral Route) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Finasteride (Oral Route) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Finasteride (Oral Route) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Finasteride (Oral Route) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Finasteride (Oral Route) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Finasteride (Oral Route) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Finasteride (Oral Route) Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Finasteride (Oral Route) Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Finasteride (Oral Route) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Finasteride (Oral Route) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Finasteride (Oral Route) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Finasteride (Oral Route) Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Finasteride (Oral Route) Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Finasteride (Oral Route) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Finasteride (Oral Route) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Finasteride (Oral Route) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Finasteride (Oral Route) by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Finasteride (Oral Route) by Type (2020-2031)
 Figure 52. Global Finasteride (Oral Route) Price (US$/Pcs) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Finasteride (Oral Route) by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Finasteride (Oral Route) by Application (2020-2031)
 Figure 55. Global Finasteride (Oral Route) Price (US$/Pcs) by Application (2020-2031)
 Figure 56. Finasteride (Oral Route) Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Finasteride Oral Tablet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Finasteride Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Benign Prostatic Hyperplasia Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Finasteride Tablet Market Research Report 2025
Global 5α Reductase Inhibitors Market Research Report 2025
Global Finasteride API Market Research Report 2024
Global Oral Testosterone Market Research Report 2025
Global Benign Prostatic Hypertrophy Medication Market Research Report 2024
Global Dutasteride API Market Research Report 2024
Global Topical Minoxidil Market Research Report 2024
Minoxidil for Hair Loss Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral GnRH Drugs Market Research Report 2024
Global Minoxidil Market Insights Forecast to 2030
Global Enzalutamide Tablets Market Research Report 2024
Testosterone Blocker Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Minoxidil Spray Market Research Report 2024
Global Albuterol Market Research Report 2024
BPH Treatment Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medication for Hair Loss Market Research Report 2024
Global Oral Drugs for Benign Prostatic Hyperplasia Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions